Assessment of Significant Pathway Signaling and Prognostic Value of GNG11 in Ovarian Serous Cystadenocarcinoma [PDF]
International Journal of General Medicine, 2021 Ming-Min Jiang, Fan Zhao, Tao-Tao Lou Department of Obstetrics and Gynaecology, Zhuji Central Hospital, Shaoxing, 311800, Zhejiang, People’s Republic of ChinaCorrespondence: Ming-Min JiangDepartment of Obstetrics and Gynaecology, Zhuji Central ...
Jiang MM, Zhao F, Lou TT
doaj +4 more sources
An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma [PDF]
International Journal of General Medicine, 2021 Fengjuan Shi,1,* Tongning Deng,2,* Jian Mo,1 Huiru Wang,1 Jianxun Lu3,4 1Department of Gynaecology and Obstetrics, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530022, People’s Republic of China; 2Department of ...
Shi F, Deng T, Mo J, Wang H, Lu J
doaj +4 more sources
The circular RNA expression profile in ovarian serous cystadenocarcinoma reveals a complex circRNA–miRNA regulatory network [PDF]
BMC Medical Genomics, 2021 Background Ovarian serous cystadenocarcinoma is one of the most serious gynecological malignancies. Circular RNA (circRNA) is a type of noncoding RNA with a covalently closed continuous loop structure. Abnormal circRNA expression might be associated with
Minhui Zhuang +5 more
doaj +2 more sources
Mining TCGA database for gene expression in ovarian serous cystadenocarcinoma microenvironment [PDF]
PeerJ, 2021 Background Ovarian cancer is one of the leading causes of female deaths worldwide. Ovarian serous cystadenocarcinoma occupies about 90% of it. Effective and accurate biomarkers for diagnosis, outcome prediction and personalized treatment are needed ...
Youzheng Xu +6 more
doaj +3 more sources
Comprehensive analysis of LDHAP5 pseudogene expression and potential pathogenesis in ovarian serous cystadenocarcinoma [PDF]
Cancer Cell International, 2020 Background We aimed to identify differentially expressed pseudogenes and explore their potential functions in four types of common gynecological malignancies (e.g., cervical squamous cell carcinoma, ovarian serous cystadenocarcinoma, uterine corpus ...
Shitong Lin +7 more
doaj +2 more sources
The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma [PDF]
Journal of Ovarian ResearchBackground Ovarian serous cystadenocarcinoma, accounting for about 90% of ovarian cancers, is frequently diagnosed at advanced stages, leading to suboptimal treatment outcomes.
Hao Qin +5 more
doaj +2 more sources
Gastric metastasis of ovarian serous cystadenocarcinoma [PDF]
International Medical Case Reports Journal, 2018 Shiqiang Yang Xintai Hospital Affiliated to Taishan Medical University, Tai’an City, People’s Republic of China Background: Gastric metastasis from ovarian serous cystadenocarcinoma is extremely rare.
Yang S
doaj +2 more sources
Identification and Validation of a Novel Anoikis-Related Signature for Predicting Prognosis and Immune Landscape in Ovarian Serous Cystadenocarcinoma [PDF]
Heliyon, 2023 Zhu Yuting, Guo Chen, Xi-Ya Jiang
exaly +2 more sources
Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous Cystadenocarcinoma [PDF]
Cancers, 2022 Savina Ferorelli +2 more
exaly +2 more sources
Identification of Bromodomain-Containing Proteins Prognostic Value and Expression Significance Based on a Genomic Landscape Analysis of Ovarian Serous Cystadenocarcinoma [PDF]
Frontiers in Oncology, 2022 Zhang J +6 more
exaly +2 more sources